TORCH Infections in Paediatrics Complete Guide to Congenital Toxoplasmosis Rubella CMV Herpes Diagnosis Management
Paediatrics

TORCH Infections in Paediatrics Complete Guide to Congenital Toxoplasmosis Rubella CMV Herpes Diagnosis Management

TORCH Infections in Paediatrics

Definition

TORCH infections are a group of congenital infections transmitted from the mother to the fetus during pregnancy or delivery. These infections can cause serious fetal and neonatal morbidity and mortality.

TORCH acronym includes:

  • T – Toxoplasmosis
  • O – Other infections (e.g., Syphilis, Varicella-zoster, Parvovirus B19, HIV, Hepatitis B)
  • R – Rubella
  • C – Cytomegalovirus (CMV)
  • H – Herpes simplex virus (HSV)

These infections are important in paediatrics because they cause congenital malformations, developmental delay, and neonatal illness.


1. Pathophysiology

Maternal infection during pregnancy leads to transplacental transmission or infection during delivery.

Main mechanisms:

  1. Transplacental spread

* Pathogens cross the placenta → infect fetal tissues.

* Causes organ damage during fetal development.

  1. Direct tissue destruction

* Viruses and parasites replicate inside fetal cells.

  1. Inflammatory damage

* Immune response leads to fibrosis, calcification, and organ dysfunction.

  1. Timing effect

* Early pregnancy infection → severe malformations.

* Late pregnancy infection → milder disease.


2. Causes / Organisms

Toxoplasmosis

Organism: Toxoplasma gondii

Transmission:

  • Undercooked meat
  • Cat feces
  • Contaminated food

Other infections

Includes:

Syphilis

  • Treponema pallidum

Varicella

  • Varicella-zoster virus

Parvovirus B19

  • Causes fetal anemia

HIV

Hepatitis B


Rubella

Virus: Rubella virus

Maternal infection in first trimester causes congenital rubella syndrome.


Cytomegalovirus (CMV)

Virus: Human cytomegalovirus

Most common congenital viral infection.

Transmission:

  • Transplacental
  • During delivery
  • Breast milk

Herpes Simplex Virus (HSV)

Virus: HSV-1 and HSV-2

Transmission mainly occurs:

  • During vaginal delivery

3. Risk Factors

  • Maternal primary infection during pregnancy
  • Lack of vaccination (rubella)
  • Poor hygiene
  • Raw meat consumption
  • Exposure to cats
  • Maternal immunosuppression

4. Clinical Features (Common TORCH Syndrome)

Classic neonatal findings:

General Features

  • Intrauterine growth restriction (IUGR)
  • Prematurity
  • Hepatosplenomegaly
  • Jaundice
  • Microcephaly
  • Hydrocephalus
  • Developmental delay

Skin

  • Petechiae
  • Purpura
  • “Blueberry muffin” rash

CNS

  • Seizures
  • Intracranial calcifications
  • Intellectual disability

Eyes

  • Cataracts
  • Chorioretinitis
  • Glaucoma

Hearing

  • Sensorineural hearing loss

5. Characteristic Findings by Infection

Toxoplasmosis

Classic triad:

  • Chorioretinitis
  • Hydrocephalus
  • Intracranial calcifications

Rubella

Congenital rubella syndrome triad:

  1. Cataracts
  2. Congenital heart disease (PDA)
  3. Sensorineural deafness

Other features:

  • Blueberry muffin rash
  • Microcephaly

CMV

Most common congenital infection.

Features:

  • Periventricular calcifications
  • Microcephaly
  • Hearing loss
  • Petechiae
  • Hepatosplenomegaly

HSV

Neonatal herpes forms:

  1. Skin-eye-mouth disease
  2. CNS encephalitis
  3. Disseminated infection

Symptoms:

  • Vesicular rash
  • Seizures
  • Lethargy

Syphilis

Features:

  • Snuffles (nasal discharge)
  • Rash on palms and soles
  • Hepatosplenomegaly

Late findings:

  • Hutchinson teeth
  • Saddle nose
  • Deafness

6. Investigations / Diagnosis

Maternal Screening

  • TORCH antibody panel

IgM → recent infection

IgG → past infection


Neonatal Tests

Blood tests:

  • TORCH IgM antibodies
  • PCR for viral DNA

Other investigations:

  • Cranial ultrasound
  • CT/MRI brain
  • Ophthalmologic examination
  • Hearing screening
  • Liver function tests

7. Differential Diagnosis

Conditions mimicking TORCH infections:

  • Neonatal sepsis
  • Genetic syndromes
  • Metabolic disorders
  • Birth trauma
  • Congenital brain malformations

8. Management

Treatment depends on the organism.


Toxoplasmosis Treatment

Drug: Pyrimethamine

Indication

Congenital toxoplasmosis

Mechanism

Inhibits protozoal dihydrofolate reductase

Dose

Infants:

1 mg/kg/day with sulfadiazine

Pharmacokinetics

  • Oral absorption
  • Hepatic metabolism

Adverse Effects

  • Bone marrow suppression
  • Rash

Contraindications

  • Folate deficiency

Monitoring

  • CBC

Counselling

  • Always give folinic acid to prevent marrow toxicity.

Drug: Sulfadiazine

Mechanism:

Inhibits folate synthesis in parasites.

Adverse effects:

  • Crystalluria
  • Hypersensitivity

CMV Treatment

Drug: Ganciclovir

Indication

Symptomatic congenital CMV

Mechanism

Inhibits viral DNA polymerase

Dose

6 mg/kg IV every 12 hours

Adverse effects

  • Neutropenia
  • Thrombocytopenia

Monitoring

CBC


Drug: Valganciclovir

Oral form of ganciclovir.

Used for 6 months therapy in infants.


HSV Treatment

Drug: Acyclovir

Indication

Neonatal herpes infection

Mechanism

Inhibits viral DNA synthesis

Dose

20 mg/kg IV every 8 hours

Duration:

  • 14–21 days

Adverse effects

  • Nephrotoxicity
  • Neutropenia

Monitoring

  • Renal function

Syphilis Treatment

Drug: Penicillin G

Indication

Congenital syphilis

Mechanism

Inhibits bacterial cell wall synthesis

Dose

50,000 units/kg IV

Adverse effects

  • Allergy
  • Jarisch-Herxheimer reaction

9. Non-Pharmacologic Management

  • Supportive neonatal care
  • Management of seizures
  • Hearing rehabilitation
  • Vision correction
  • Developmental therapy
  • Nutritional support

10. Prevention

Maternal Measures

  • Rubella vaccination before pregnancy
  • Avoid raw meat
  • Avoid cat litter exposure
  • Safe sexual practices
  • Screening during pregnancy

Neonatal Prevention

  • HSV infected mothers → Cesarean delivery
  • CMV hygiene precautions
  • Early screening

11. Prognosis

Depends on:

  • Type of infection
  • Timing during pregnancy
  • Early treatment

Possible long-term complications:

  • Deafness
  • Intellectual disability
  • Vision loss
  • Epilepsy

If you want, I can also give:

  • 25–30 MCQs on TORCH infections (paediatrics exams)
  • FAQ JSON format
  • Short exam revision notes for MBBS / NEET-PG / USMLE.

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

TORCH infections are a group of congenital infections transmitted from mother to fetus during pregnancy or delivery. TORCH stands for Toxoplasmosis, Other infections such as syphilis and varicella, Rubella, Cytomegalovirus, and Herpes simplex virus. These infections can cause serious neonatal complications including developmental delay, congenital anomalies, hearing loss, and neurological damage.
TORCH infections are important because they can cause congenital malformations, intrauterine growth restriction, neurological damage, and long term developmental problems in newborns. Early diagnosis and treatment are essential to reduce complications.
Common symptoms include microcephaly, hydrocephalus, intracranial calcifications, hepatosplenomegaly, jaundice, seizures, developmental delay, cataracts, chorioretinitis, sensorineural hearing loss, and a blueberry muffin rash.
The classic triad of congenital toxoplasmosis includes chorioretinitis, hydrocephalus, and intracranial calcifications.
Congenital rubella syndrome classically presents with cataracts, congenital heart disease such as patent ductus arteriosus, and sensorineural hearing loss.
Cytomegalovirus infection is the most common congenital viral infection and a leading cause of non genetic sensorineural hearing loss in children.
Diagnosis is made using serological tests for TORCH IgM antibodies, PCR tests for viral DNA or RNA, imaging studies such as ultrasound or CT scan of the brain, ophthalmologic examination, and hearing screening.
Symptomatic congenital cytomegalovirus infection is treated with antiviral medications such as ganciclovir or valganciclovir to reduce complications including hearing loss.
Congenital toxoplasmosis is treated with a combination of pyrimethamine, sulfadiazine, and folinic acid to eliminate the parasite and reduce bone marrow toxicity.
Prevention includes rubella vaccination before pregnancy, avoiding undercooked meat, practicing good hygiene, avoiding contact with cat litter, screening during pregnancy, and proper management of maternal infections.